News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Tanya Jindal: Biomarkers associated with response to EV monotherapy in patients with Advanced Urothelial Carcinoma
Tanya Jindal/X
Dec 26, 2024, 14:42

Tanya Jindal: Biomarkers associated with response to EV monotherapy in patients with Advanced Urothelial Carcinoma

Tanya Jindal, Physician Scientist at Interested in GU Oncology, shared a recent article on X:

“Check out our paper in European Urology Oncology (EUO) highlighting biomarkers associated with response to EV monotherapy in patients with advanced Urothelial Carcinoma.

TMB high associated with improved OS.

CDKN2A/B associated with decreased PFS.”

Title: Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data

Authors: Tanya Jindal, Cindy Jiang, Omar Alhalabi, Amanda Nizam, Charles Nguyen, Rafee Talukder, Dimitra Bakaloudi, Matthew Davidsohn, Dory Freeman, Michael Glover, Ali Raza Khaki, Sean Evans, Emily Lemke, Rohit Bose, Woogwang Sim, Cameron Pywell, Arnab Basu, Deepak Kilari, Pedro C. Barata, Mehmet A. Bilen, Yousef Zakharia, Matthew I. Milowsky, Sumit A. Shah, Joaquim Bellmunt, Petros Grivas, Hamid Emamekhoo, Nancy B. Davis, Shilpa Gupta, Christopher Hoimes, Matthew T. Campbell, Ajjai Alva and Vadim S. Koshkin

Tanya Jindal

For more updates, follow OncoDaily.

Amanda Nizam cancer Charles Nguyen Cindy Jiang Dimitra Bakaloudi EUO EV monotherapy Omar Alhalabi OncoDaily Oncology Rafee Talukder Tanya Jindal urothelial carcinoma Vadim S Koshkin
Special Coverage
Science
Aug 8, 2025, 05:01
Arndt Vogel: ESMO-MCBS 2.0 Scorecards for Hepatocellular Carcinoma
Oncolibrary
Aug 8, 2025, 03:13
CAR T-Cell Therapy vs iNKT Cell Therapy: The Future of Engineered Immune Cells in Cancer Treatment
Oncolibrary
Aug 8, 2025, 03:09
Immunotherapy for Cancer Success Rate: What Patients Need to Know in 2025
Oncolibrary
Aug 8, 2025, 01:07
10-Minute Immunotherapy Infusion: Safe, Efficient Delivery of Nivolumab and Pembrolizumab
Societies
Aug 7, 2025, 23:50
Because Every Patient Matters: Promoting Diversity in Cancer Support - MASCC
Blog
Aug 7, 2025, 22:17
Arif Kamal: ACS is Celebrating 60 Years of Community-Driven Primary Care at Health Centers
Blog
Aug 7, 2025, 21:48
Michael Ziener: NFL and ACS Join Forces to Expand Cancer Screening Access
Blog
Aug 7, 2025, 21:02
John V. Oyler: Q2 2025 Marks Another Strong Quarter for BeOne Medicines
Insight
Aug 7, 2025, 20:53
Luke Dow: The Complexity of Drug Resistance in Colorectal Cancer
Career
Aug 7, 2025, 20:24
Elizabeth Ugwoma Awo-Ejeh: Grateful to Have Been Selected as One of the Dicey Scroggins Patient Advocacy Fellows
Blog
Aug 7, 2025, 20:07
MaryRose Mazzola: $130K Raised for the Dana-Farber Cancer Institute and The Scars Foundation
Blog
Aug 7, 2025, 19:57
Carmen Monge-Montero: Where You're Born Should not Determine if You Survive